{"companyId":272661,"requestedLanguage":"ja","resolvedLanguage":"ja","availableLanguages":["en","ja"],"companyName":"サジメットバイオサイエンス株式会社","headOfficeLocation":"カリフォルニア州サンマテオ、ボヴェットロード155番地、スイート303、94402","presidentName":"デイビッド・ハッペル","companySummary":null,"stockCode":"SGMT","currency":"USD","capital":null,"sales":null,"employees":null,"employeesConsolidated":null,"humanCheck":false,"domains":["sagimet.com"],"businessContents":["肝臓疾患を含む代謝性疾患の治療薬を開発しています。","非アルコール性脂肪肝炎の治療のための脂肪酸シンターゼ阻害剤を開発しています。"],"relations":[],"dataSources":[{"detailNumber":1,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465926026140/sgmt-20251231x10k.htm","scoreAbout":500,"scoreBusiness":0,"scoreGroup":0,"scoreCustomer":0}]}